181 related articles for article (PubMed ID: 27811231)
1. Genetic and hormonal control of hepatic steatosis in female and male mice.
Norheim F; Hui ST; Kulahcioglu E; Mehrabian M; Cantor RM; Pan C; Parks BW; Lusis AJ
J Lipid Res; 2017 Jan; 58(1):178-187. PubMed ID: 27811231
[TBL] [Abstract][Full Text] [Related]
2. Loss of hepatic PPARα promotes inflammation and serum hyperlipidemia in diet-induced obesity.
Stec DE; Gordon DM; Hipp JA; Hong S; Mitchell ZL; Franco NR; Robison JW; Anderson CD; Stec DF; Hinds TD
Am J Physiol Regul Integr Comp Physiol; 2019 Nov; 317(5):R733-R745. PubMed ID: 31483154
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance, steatohepatitis, and hepatocellular carcinoma in a new congenic strain of Fatty Liver Shionogi (FLS) mice with the Lep(ob) gene.
Soga M; Hashimoto S; Kishimoto Y; Hirasawa T; Makino S; Inagaki S
Exp Anim; 2010; 59(4):407-19. PubMed ID: 20660987
[TBL] [Abstract][Full Text] [Related]
4. Effect of Octreotide on Hepatic Steatosis in Diet-Induced Obesity in Rats.
Li M; Ye T; Wang XX; Li X; Qiang O; Yu T; Tang CW; Liu R
PLoS One; 2016; 11(3):e0152085. PubMed ID: 27002331
[TBL] [Abstract][Full Text] [Related]
5. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
6. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
[TBL] [Abstract][Full Text] [Related]
7. iPLA2β deficiency attenuates obesity and hepatic steatosis in ob/ob mice through hepatic fatty-acyl phospholipid remodeling.
Deng X; Wang J; Jiao L; Utaipan T; Tuma-Kellner S; Schmitz G; Liebisch G; Stremmel W; Chamulitrat W
Biochim Biophys Acta; 2016 May; 1861(5):449-61. PubMed ID: 26873633
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in human carboxylesterase CES1 confers resistance to hepatic steatosis.
Lian J; Bahitham W; Panigrahi R; Nelson R; Li L; Watts R; Thiesen A; Lemieux MJ; Lehner R
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jul; 1863(7):688-699. PubMed ID: 29631096
[TBL] [Abstract][Full Text] [Related]
9. Dietary treatment of fatty liver: High dietary protein content has an antisteatotic and antiobesogenic effect in mice.
Garcia Caraballo SC; Comhair TM; Dejong CHC; Lamers WH; Koehler SE
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1789-1804. PubMed ID: 28457799
[TBL] [Abstract][Full Text] [Related]
10. Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis.
Dongiovanni P; Romeo S; Valenti L
Biomed Res Int; 2015; 2015():460190. PubMed ID: 26273621
[TBL] [Abstract][Full Text] [Related]
11. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.
Bril F; Sninsky JJ; Baca AM; Superko HR; Portillo Sanchez P; Biernacki D; Maximos M; Lomonaco R; Orsak B; Suman A; Weber MH; McPhaul MJ; Cusi K
J Clin Endocrinol Metab; 2016 Feb; 101(2):644-52. PubMed ID: 26672634
[TBL] [Abstract][Full Text] [Related]
12. Histone H3K9 demethylase JMJD2B induces hepatic steatosis through upregulation of PPARγ2.
Kim JH; Jung DY; Nagappan A; Jung MH
Sci Rep; 2018 Sep; 8(1):13734. PubMed ID: 30214048
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor binding protein 7 accelerates hepatic steatosis and insulin resistance in non-alcoholic fatty liver disease.
Yan H; Li T; Wang Y; Li H; Xu J; Lu X
Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1101-1110. PubMed ID: 31397492
[TBL] [Abstract][Full Text] [Related]
14. Early hypermethylation of hepatic Igfbp2 results in its reduced expression preceding fatty liver in mice.
Kammel A; Saussenthaler S; Jähnert M; Jonas W; Stirm L; Hoeflich A; Staiger H; Fritsche A; Häring HU; Joost HG; Schürmann A; Schwenk RW
Hum Mol Genet; 2016 Jun; 25(12):2588-2599. PubMed ID: 27126637
[TBL] [Abstract][Full Text] [Related]
15. Platycodon grandiflorus Root Extract Attenuates Body Fat Mass, Hepatic Steatosis and Insulin Resistance through the Interplay between the Liver and Adipose Tissue.
Kim YJ; Choi JY; Ryu R; Lee J; Cho SJ; Kwon EY; Lee MK; Liu KH; Rina Y; Sung MK; Choi MS
Nutrients; 2016 Aug; 8(9):. PubMed ID: 27589792
[TBL] [Abstract][Full Text] [Related]
16. Niacin increases diet-induced hepatic steatosis in B6129 mice.
Fang H; Li Z; Graff EC; McCafferty KJ; Judd RL
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Sep; 1865(9):158731. PubMed ID: 32404278
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
[TBL] [Abstract][Full Text] [Related]
18. Metabolic phenotype and adipose and liver features in a high-fat Western diet-induced mouse model of obesity-linked NAFLD.
Luo Y; Burrington CM; Graff EC; Zhang J; Judd RL; Suksaranjit P; Kaewpoowat Q; Davenport SK; O'Neill AM; Greene MW
Am J Physiol Endocrinol Metab; 2016 Mar; 310(6):E418-39. PubMed ID: 26670487
[TBL] [Abstract][Full Text] [Related]
19. GLP-1 Elicits an Intrinsic Gut-Liver Metabolic Signal to Ameliorate Diet-Induced VLDL Overproduction and Insulin Resistance.
Khound R; Taher J; Baker C; Adeli K; Su Q
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2252-2259. PubMed ID: 29074588
[TBL] [Abstract][Full Text] [Related]
20. Galectin-3 Ablation Enhances Liver Steatosis, but Attenuates Inflammation and IL-33-Dependent Fibrosis in Obesogenic Mouse Model of Nonalcoholic Steatohepatitis.
Jeftic I; Jovicic N; Pantic J; Arsenijevic N; Lukic ML; Pejnovic N
Mol Med; 2015 May; 21(1):453-65. PubMed ID: 26018806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
